Overview

Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the activity of UR-63325 in a model of allergic rhinitis induced by nasal allergen challenge to known allergic rhinitis patients otherwise healthy.
Phase:
Phase 2
Details
Lead Sponsor:
Palau Pharma S.A.
Treatments:
Fluticasone
Xhance